ANGELA POLLITT: Open Payments
NPI 1033598222 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 92 payments from 18 companies in 2025. Trend: 2023 $247 · 2024 $120 · 2025 $1,501
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $493 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $174 |
| Madrigal Pharmaceuticals | 5 | $162 |
| QOL Medical, LLC | 6 | $137 |
| Celltrion USA Inc. | 5 | $85 |
| Ardelyx, Inc. | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| PFIZER INC. | 2 | $43 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
Products named: RINVOQ, REZDIFFRA, XIFAXAN, Sucraid, SKYRIZI, MAVYRET, VEGZELMA, IBSRELA.
Industry payments across OH — which companies pay providers there.
